Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 30;14(3):540-552.
doi: 10.21037/tau-24-617. Epub 2025 Mar 26.

Evaluation of different methods for antibody titre determination in ABO-incompatible kidney transplantation

Affiliations

Evaluation of different methods for antibody titre determination in ABO-incompatible kidney transplantation

Shanshan Zhou et al. Transl Androl Urol. .

Abstract

Background: Blood type antibody-mediated rejection is considered the main obstacle to ABO blood type-incompatible kidney transplantation. Choosing an appropriate antibody-level determining method and setting a rational baseline are critical for safely conducting ABO-incompatible kidney allografts. However, due to the differences in antibody detection methods between laboratories, there is no unified baseline to confirm the true titer. Therefore, a generally applicable method must be selected to determine the level of anti-ABO antibodies before surgery, and the actual critical titer level should be set accordingly. This study aims to guide the selection of appropriate antibody titer detection methods for ABO-incompatible kidney transplant recipients by comparing the differences in titer results obtained through various detection methods.

Methods: A total of 210 ethylene diamine tetraacetic acid (EDTA)-anticoagulated samples were obtained from patients before or after ABO-I kidney transplantation in our centre. In this study, we tested immunoglobulin M (IgM) and immunoglobulin G (IgG) ABO antibody titres using different detection methods, i.e., a tube test (TT), a microcolumn gel card test (MGT), and a glass bead card test (GBT), to evaluate deviations in antibody levels.

Results: According to our results, the IgM titre presented by the TT varied less than one standard dilution from that of the MGT; while the TT resulted in a 2 to 4 titre deviation from that determined by the GBT. For IgG, the titres obtained by the MGT were always one standard dilution higher than those obtained by the TT, and the TT-based and GBT-based titres differed by 2-3 serial dilution steps.

Conclusions: It is important that clinical laboratories employ a consistent method of sample testing for a particular patient, and indicate the approach used when reporting results. A further clinical retrospective study revealed that the MGT could effectively monitor titre changes following surgery.

Keywords: ABO incompatibility; Titre; glass bead card test (GBT); microcolumn gel card test (MGT); tube test (TT).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-24-617/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Titre distribution for the non-O blood group. Overall antibody titre distribution for the non-O blood group. (A,B) Distribution of the anti-A IgM titres in blood group B and anti-B IgM titres in blood group A samples. (C,D) Distribution of the anti-A IgG titres in blood group B and anti-A IgG titres in blood group A samples (n=70). IgG, immunoglobulin G; IgM, immunoglobulin M; TT, tube test; MGT, microcolumn gel card test; GBT, glass bead card test.
Figure 2
Figure 2
Titre distribution in the O blood group. Overall antibody titre distribution in the O blood group. (A,B) Distribution of anti-A (A) and anti-B (B) IgM titres in blood group O samples. (C,D) Distribution of anti-A (C) and anti-B (D) IgG titres in blood group O samples (n=70). IgG, immunoglobulin G; IgM, immunoglobulin M; GBT, glass bead card test; MGT, microcolumn gel card test; TT, tube test.
Figure 3
Figure 3
Comparison of anti-A/B antibody titres among three methods in non-O blood group. Comparison of the anti-A/B antibody titres obtained using the GBT, MGT, and TT methods in the non-O blood group. The horizontal lines in the middle of each group represent the median values of the variance. (A,B) IgM antibody titres in blood group A and blood group B, respectively. (C,D) IgG antibody titres in blood group A and blood group B, respectively. IgG, immunoglobulin G; IgM, immunoglobulin M; GBT, glass bead card test; MGT, microcolumn gel card test; TT, tube test.
Figure 4
Figure 4
Comparison of the anti-A/B antibody titres as determined by the three methods in the O blood group. Comparison of the anti-A/B antibody titres obtained using the GBT, MGT, and TT methods in the non-O blood group. The horizontal lines in the middle of each group represent the median values of the variance. (A,B) Anti-A and anti-B IgM antibody titres in blood group O, respectively. (C,D) Anti-A and anti-B IgG antibody titres in blood group O, respectively. IgG, immunoglobulin G; IgM, immunoglobulin M; TT, tube test; MGT, microcolumn gel card test; GBT, glass bead card test.
Figure 5
Figure 5
Creatinine and ABO antibody titres before and after plasmapheresis. (A) The creatinine levels and anti-A titres of patient 1; (B) the creatinine levels and anti-B titres of patient 2. pre-op, pre-operation; post-op, post-operation; GBT, glass bead card test; IgG, immunoglobulin G; IgM, immunoglobulin M; MGT, microcolumn gel card test; PE, plasma exchange; TT, tube test.

Similar articles

References

    1. Ishida H, Kondo T, Shimizu T, et al. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation. Transpl Int 2015;28:286-96. 10.1111/tri.12482 - DOI - PubMed
    1. Morozumi K, Takeda A, Otsuka Y, et al. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation. Nephrology (Carlton) 2016;21 Suppl 1:4-8. 10.1111/nep.12777 - DOI - PubMed
    1. Naik RH, Shawar SH. Renal Transplantation Rejection. Treasure Island (FL): StatPearls Publishing; 2025.
    1. Justiz Vaillant AA, Mohseni M. Chronic Transplantation Rejection. Treasure Island (FL): StatPearls Publishing; 2025.
    1. Kahwaji J, Vo AA, Jordan SC. ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation? Expert Rev Clin Immunol 2010;6:893-900. 10.1586/eci.10.78 - DOI - PubMed

LinkOut - more resources